CASCADIAN THERAPEUTICS, INC. (CASC) financial statements (2020 and earlier)

Company profile

Business Address 3101 WESTERN AVE.
SEATTLE, WA 98121
State of Incorp. DE
Fiscal Year End December 31
SIC 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments936356586081
Cash and cash equivalents17142810922
Short-term investments774929475159
Receivables    00
Prepaid expense and other current assets1
Other undisclosed current assets22211 
Total current assets:956458596182
Noncurrent Assets
Property, plant and equipment112222
Long-term investments and receivables8  6133
Long-term investments8  6133
Intangible assets, net (including goodwill)1717363622
Goodwill1717171722
Intangible assets, net (excluding goodwill)  2020  
Other noncurrent assets11010
Prepaid expense and other noncurrent assets1
Deferred tax assets, net   000
Other undisclosed noncurrent assets   (0)(0)(0)
Total noncurrent assets:26193945177
TOTAL ASSETS:12183971037889
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1185443
Accounts payable210111
Accrued liabilities633231
Employee-related liabilities342211
Deferred tax liabilities   000
Other undisclosed current liabilities000(0)(0)(0)
Total current liabilities:1295553
Noncurrent Liabilities
Liabilities, other than long-term debt 08701
Deferred revenue and credits   001
Deferred tax liabilities, net  77  
Other liabilities 01   
Other undisclosed noncurrent liabilities    14
Total noncurrent liabilities: 08724
Total liabilities:129121267
Stockholders' equity
Stockholders' equity attributable to parent1097484917282
Common stock354354354354354354
Additional paid in capital390298250225155127
Accumulated other comprehensive loss(5)(5)(5)(5)(5)(5)
Accumulated deficit(629)(572)(515)(482)(432)(393)
Total stockholders' equity:1097484917282
Other undisclosed liabilities and equity0000  
TOTAL LIABILITIES AND EQUITY:12183971037889

Income statement (P&L) ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenue, net     4
Other income 00
Gross profit: 00  4
Operating expenses(58)(65)(33)(51)(41)(28)
Other undisclosed operating loss (0)(0)  (4)
Operating loss:(58)(65)(33)(51)(41)(28)
Nonoperating income1001225
Other nonoperating income (expense)10000(0)
Interest and debt expense     (1)
Other undisclosed income from continuing operations before equity method investments, income taxes     1
Loss from continuing operations before income taxes:(57)(65)(33)(50)(39)(3)
Income tax benefit 7    
Net loss attributable to parent:(57)(58)(33)(50)(39)(3)
Other undisclosed net loss available to common stockholders, basic(1)(3)    
Net loss available to common stockholders, basic:(58)(60)(33)(50)(39)(3)
Other undisclosed net loss available to common stockholders, diluted     (26)
Net loss available to common stockholders, diluted:(58)(60)(33)(50)(39)(29)

Comprehensive Income ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(57)(58)(33)(50)(39)(3)
Other comprehensive income (loss)(0)(0)0(0)(0)0
Comprehensive loss, net of tax, attributable to parent:(57)(58)(33)(50)(39)(3)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: